Journal of Insurance Medicine,
Год журнала:
2024,
Номер
51(2), С. 111 - 115
Опубликована: Июль 1, 2024
Context.—
As
the
Covid-19
pandemic
continues
into
its
4th
year,
reports
of
long-term
morbidity
and
mortality
are
now
attracting
attention.
Recent
studies
suggest
that
survivors
at
increased
risk
common
illnesses,
such
as
myocardial
infarction,
diabetes
mellitus
autoimmune
disorders.
Mortality
may
also
be
increased.
This
article
will
review
evidence
supports
some
these
observations
provide
an
opinion
about
their
validity
relevance
to
insured
cohorts.
European Journal of General Practice,
Год журнала:
2023,
Номер
29(2)
Опубликована: Июнь 1, 2023
Background
Fear
of
coronavirus
disease
(COVID-19)
has
been
associated
with
significant
health
effects.Objectives
To
assess
COVID-19
fear
and
investigate
factors
higher
among
survivors
over
6
months
after
infection.Methods
Cross-sectional
study
using
multistage
sampling
(family
practices
within
the
highest
5th
percentile
numbers
SARS-CoV-2
infected
patients
random
sample
these
practices)
performed
from
March
15
to
17
July
2021.
Adult
a
laboratory-confirmed
history
were
recruited
for
self-administered
79-item
questionnaire
including
demographics,
self-rated
health,
physical
activity,
characteristics,
severity
Scale
(FCV-19S).
Comorbidity
data
extracted
Estonian
Health
Insurance
Fund.
Logistic
regression
models
used
evaluate
fear.Results
Of
341
participants
included,
60%
women,
24.2%
hospitalised
due
22.2%
had
long
COVID,
143
(42%)
reported
high
levels
(cut-off
FCV-19S
>17.8).
Higher
was
being
female
(aOR
2.12,
95%
CI
1.14–3.95),
age
≥61
years
3.23,
1.28–8.16),
two-member-households
3.70,
1.40–9.77)
inactivity
prior
3.53,
1.26–9.95),
symptom
during
acute
COVID-19.
Long
COVID
not
1.82
0.91–3.63).Conclusion
Almost
half
more
than
infection.
Greater
sociodemographic
factors,
activity
severity.
There
is
need
target
this
population
develop
appropriate
interventions.
Revista do Instituto de Medicina Tropical de São Paulo,
Год журнала:
2024,
Номер
66
Опубликована: Янв. 1, 2024
In
Brazil,
the
COVID-19
burden
was
substantial,
and
risk
factors
associated
with
higher
in-hospital
mortality
rates
have
been
extensively
studied.
However,
information
on
short-term
all-cause
death
in
patients
who
survived
hospitalization
period
of
acute
SARS-CoV-2
infection
is
limited.
We
analyzed
six-month
post-hospitalization
rate
possible
a
single
center
Brazil.
This
retrospective
cohort
study
focused
follow-up.
The
exclusion
criteria
were
during
hospitalization,
transference
to
another
hospital,
age
under
18.
collected
data
from
charts
all
hospitalized
March
2020
December
positive
RT-PCR
test
for
SARS-CoV-2,
resulting
sample
size
106
patients.
main
outcome
after
whereas
comorbidities
demographics
evaluated
as
factors.
crude
16%.
first
30
days
follow-up
had
highest
rate.
Cox
regression
model
mortality,
previous
chronic
kidney
disease
(HR,
4.06,
95%CI
1.46
–
11.30)
longer
hospital
stay
(HR
1.01,
1.00
1.02)
only
statistically
death.
conclusion,
high
observed.
Within
follow-up,
observed
prior
CKD
stay.
These
findings
highlight
importance
more
intensive
medical
surveillance
this
period.
Diseases,
Год журнала:
2024,
Номер
12(6), С. 123 - 123
Опубликована: Июнь 5, 2024
Background:
The
long-term
survival
of
patients
hospitalized
with
COVID-19
and
the
factors
associated
poorer
months
after
infection
are
not
well
understood.
aims
present
study
were
to
analyze
overall
mortality
10
admission.
Methods:
762
disease
included.
Patients
underwent
a
complete
clinical
evaluation,
routine
laboratory
analysis
chest
X-ray.
Data
collected
included
demographic
data,
such
as
vascular
risk
factors,
tobacco
or
alcohol
use,
comorbidity,
institutionalization.
Results:
Ten-month
was
25.6%:
108
deaths
occurred
in-hospital,
while
87
died
discharge.
In-hospital
independently
related
NT-proBNP
values
>
503.5
pg/mL
[OR
=
4.67
(2.38–9.20)],
urea
37
mg/dL
[3.21
(1.86–7.31)]
age
older
than
71
years
1.93
(1.05–3.54)].
5.00
(3.06–8.19)],
[3.51
(1.97–6.27)],
cognitive
impairment
1.96
(1.30–2.95),
cancer
2.23
(1.36–3.68),
leukocytes
6330/mm3
1.64
(1.08–2.50)],
mortality.
Conclusions:
death
remains
high
even
infection.
Overall
during
hospital
discharge
is
nearly
that
observed
Comorbidities
impairment,
organ
dysfunction
inflammatory
reaction
independent
prognostic
markers
Journal of Insurance Medicine,
Год журнала:
2024,
Номер
51(2), С. 111 - 115
Опубликована: Июль 1, 2024
Context.—
As
the
Covid-19
pandemic
continues
into
its
4th
year,
reports
of
long-term
morbidity
and
mortality
are
now
attracting
attention.
Recent
studies
suggest
that
survivors
at
increased
risk
common
illnesses,
such
as
myocardial
infarction,
diabetes
mellitus
autoimmune
disorders.
Mortality
may
also
be
increased.
This
article
will
review
evidence
supports
some
these
observations
provide
an
opinion
about
their
validity
relevance
to
insured
cohorts.
